Back to EventsClinical Trial

New Trial: The PREVENT Resilience Study

PTSD is one of the most universal and severe psychiatric disorders whose incidence continues to rise due to the common exposure to severe trauma in the United States and worldwide. After trauma, a proportion of individuals maintains high symptoms of...

Body Mind StateJune 30, 20263 min read
New Trial: The PREVENT Resilience Study

Trial Overview

NCT ID: NCT07568145 Phase: NA Enrollment Target: 50 Status: Recruiting

PTSD is one of the most universal and severe psychiatric disorders whose incidence continues to rise due to the common exposure to severe trauma in the United States and worldwide. After trauma, a proportion of individuals maintains high symptoms of PTSD and depression, which can persist for years. The early weeks following trauma present a unique opportunity to deliver early interventions that can prevent chronic PTSD and depression from occurring, and the researchers propose a brain-based intervention that will reduce reactivity to threat, an early risk mechanism for chronic PTSD. This study is being done to learn more about whether brain stimulation in the weeks after a trauma can change brain activity that is linked to Post-Traumatic Stress Disorder (PTSD).

Why This Matters

[Draft — editorial context needed]

Source

Event Website
ClinicalTrials.gov
Visit Event →

Related

Stay Regulated

Regulate your nervous system from the inside out.

New research, honest product reviews, neurotech funding rounds, and events — delivered weekly, with zero sponsors or ads.